Finance

Lists
4886:TYO
ASKA Pharmaceutical Holdings Co Ltd
JP¥2 176,00
+1,26%
(+27,00) 1D
12 Nov., 09:58:55 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4886...
Open
JP¥2 149
High
JP¥2 180
Low
JP¥2 149
Mkt. cap
62,59 mjd
Avg. vol.
73,09 k
Volume
10,10 k
Dividend
2,99%
Quarterly dividend
JP¥16
Ex-dividend date
29 Sep. 2026
P/E ratio
11,88
52-wk high
JP¥3 045
52-wk low
JP¥1 917
EPS
JP¥183
No. of employees
2 k
Open
JP¥2 149
High
JP¥2 180
Low
JP¥2 149
Mkt. cap
62,59 mjd
Avg. vol.
73,09 k
Volume
10,10 k
Dividend
2,99%
Quarterly dividend
JP¥16
Ex-dividend date
29 Sep. 2026
P/E ratio
11,88
52-wk high
JP¥3 045
52-wk low
JP¥1 917
EPS
JP¥183
No. of employees
2 k
News stories
From web sources and news partners
About ASKA Pharmaceutical Holdings Co Ltd
CEO-
Employees1,61 k
Founded01 Apr. 2021
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
19,23 mjd
16,64 mjd
17,38 mjd
18,24 mjd
Cost of goods sold
9,89 mjd
8,82 mjd
9,30 mjd
9,53 mjd
Cost of revenue
9,89 mjd
8,82 mjd
9,30 mjd
9,53 mjd
Research and development expenses
-
7,06 mjd
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,08 mjd
-140,00 m
7,38 mjd
6,68 mjd
Operating expense
7,08 mjd
6,90 mjd
7,38 mjd
6,68 mjd
Total operating expenses
16,97 mjd
15,72 mjd
16,67 mjd
16,21 mjd
Operating income
2,26 mjd
922,00 m
712,00 m
2,03 mjd
Other non operating income
-24,00 m
54,00 m
67,00 m
35,00 m
EBT including unusual items
2,19 mjd
2,04 mjd
817,00 m
2,04 mjd
EBT excluding unusual items
2,12 mjd
811,00 m
817,00 m
2,04 mjd
Income tax expense
546,00 m
445,00 m
284,00 m
474,00 m
Effective tax rate
24,90%
21,80%
34,76%
23,19%
Other operating expenses
-
-
-
-
Net income
1,68 mjd
1,52 mjd
533,00 m
1,47 mjd
Net profit margin
8,72%
9,13%
3,07%
8,07%
Earnings per share
-
-
-
-
Interest and investment income
164,00 m
30,00 m
194,00 m
18,00 m
Interest expense
-53,00 m
-60,00 m
-93,00 m
-
Net interest expenses
111,00 m
-30,00 m
101,00 m
18,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-
1,69 mjd
-
2,78 mjd
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme